MyJournals Home  

RSS FeedsChronic unilateral chemosis following the use of amlodipine besylate (BMC Ophthalmology)

 
 

22 october 2014 00:30:15

 
Chronic unilateral chemosis following the use of amlodipine besylate (BMC Ophthalmology)
 


Background: This case report describes a patient with chronic unilateral chemosis, likely due to treatment with amlodipine besylate.Case presentationA 52-year-old man visited the clinic with symptoms of foreign body sensation and puffiness in his right eye, which had persisted for 4 months. There were no other symptoms, such as itching and pain, in his right eye and no specific symptoms in his left eye. He had been treated for hypertension and hyperlipidemia for the previous 5 months with once daily amlodipine besylate/atorvastatin (Caduet) and candesartan cilexetil (Atacand). Examination revealed marked swelling of the inferior bulbar conjunctiva in the right eye. Evaluation revealed no specific causes for the longstanding chemosis. A change of medication to telmisartan/hydrochlorothiazide (Micardis Plus) without amlodipine besylate resulted in significant improvements in his symptoms after 1 month and complete remission after 8 months. Conclusion: Prior to invasive evaluation including biopsy, specific drugs should be considered as possible causes of idiopathic longstanding conjunctival chemosis.


 
120 viewsCategory: Pathology
 
Japanese founder duplications/triplications involving BHLHA9 are associated with split-hand/foot malformation with or without long bone deficiency and Gollop-Wolfgang complex (Orphanet Journal of Rare Diseases)
Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma (BMC Clinical Pathology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten